Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Bortezomib liquid Spirig HC®:Spirig HealthCare AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
L01XX32 - BortezomibATC-DDD Version 2016. Source: WHO
L - Antineoplastic and Immunomodulating Agents

This group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.

L01 - Antineoplastic Agents

Combination products are classified in L01XY - Combinations of antineoplastic agents.
Detoxifying agents used in connection with high dose treatment of antineoplastic agents are classified in V03AF (e.g. calcium folinate).
Radiopharmaceuticals used in the treatment of cancer are classified in V10X.

No DDDs have been established because of highly individualised use and wide dosage ranges. The doses used vary substantially because of various types and severity of neoplastic diseases, and also because of the extensive use of combination therapy.
The consumption of the antineoplastic agents is in some countries measured in grams. This is recommended as a method to be used internationally for these particular agents.

L01X - Other Antineoplastic Agents

This group comprises antineoplastic preparations which cannot be classified in the preceding groups.

L01XX - Other Antineoplastic Agents

Also antineoplastic agents for dermatological use are classified here.
All asparaginases regardless of origins are classified in L01XX02. The
50-series codes are used for single substances due to lack of numbers.
Phosphatidylinositol-3-kinase (Pi3K) inhibitors are classified in L01EM.

L01XX32 - Bortezomib
2021 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home